Learn more

UNIV HEALTH NETWORK

Overview
  • Total Patents
    1,050
  • GoodIP Patent Rank
    2,548
  • Filing trend
    ⇩ 11.0%
About

UNIV HEALTH NETWORK has a total of 1,050 patent applications. It decreased the IP activity by 11.0%. Its first patent ever was published in 1995. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are UNIV OREGON HEALTH & SCIENCE, NAT UNIV CORP TOKYO MED & DENT and INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM).

Patent filings per year

Chart showing UNIV HEALTH NETWORKs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Pauls Heinz W 110
#2 Sampson Peter Brent 87
#3 Li Sze-Wan 81
#4 Keller Gordon 80
#5 Liu Yong 75
#6 Laufer Radoslaw 71
#7 Patel Narendra Kumar B 64
#8 Feher Miklos 63
#9 Ng Grace 45
#10 Pan Guohua 45

Latest patents

Publication Filing date Title
US2021100436A1 System and method for operating a ureteroscope irrigation device
WO2021046655A1 Detection of circulating tumor dna using double stranded hybrid capture
WO2021022367A1 Methods of identifying cis-regulatory elements and uses thereof
WO2021019474A1 Mhc class ii molecules and methods of use thereof
WO2021019477A1 T cell receptors and methods of use thereof
WO2021019473A1 Mhc class ii molecules and methods of use thereof
WO2021019472A1 T cell receptors and methods of use thereof
WO2021019471A1 T cell receptors and methods of use thereof
WO2021019475A1 Mhc class ii molecules and methods of use thereof
WO2021019476A1 Methods of identifying t cell receptors
WO2020257940A1 Furosemide analogues and compositions and uses thereof for treatment of alzheimer's disease
WO2020245747A1 Methods of making and using liver cells
US2020367970A1 System and method for multi-client deployment of augmented reality instrument tracking
WO2020223813A1 Nanoemulsion with porphyrin shell
WO2020223816A1 Intelligent vector electrode for a pacemaker or an implantable cardioverter-defibrillator
WO2020227232A2 Cardiomyocyte compositions and use thereof
WO2020215155A1 Crystal form s4 of the plk4 inhibitor (1r,2s)-(e)-2-(3-(4-((cis-2,6-dimethylmorpholino)methyl)styryl)- 1 h-imidazol-6- yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one fumarate
WO2020201969A1 System and method for remote patient monitoring
WO2020194195A1 T cell receptors and methods of use thereof
TW202100551A Tsg-6 antibodies and uses therefor